Evaluation Only. Created with Aspose.PDF. Copyright 2002-2021 Aspose Pty Ltd.
2224 Sharma et al.
Asian J. Chem.
General procedure for the preparation of compounds
(a-h): A mixture of oxazolone (1 g, 4.2 mmol), aromatic amine
{naphthylamine (0.31 g, 2.2 mmol) or 4-aminoazobenzene
(0.45 g, 2.3 mmol)} and ZnCl2 (0.18 g, 1.3 mmol) in 10 mL
THF was refluxed at 80-110 °C for 1 h. TLC (10 % acetone/
hexane) check was performed for determining the progress of
the reaction. After 1.5 h, anhydrous ZnCl2 (0.38 g, 2.8 mmol)
and aromatic aldehyde {1-naphthaldehyde (0.55 g, 3.5 mmol)
and 9-anthraldehyde (0.23 g, 1.1 mmol)} and 10 mL THF
was added to the reaction mixture and the reflux continued for
another 3 h at 80-110 °C. TLC showed single spot confirming
the formation of product. The products were recrystallized
with ethyl acetate and hexane.
Orange crystals;Yield 80 %; m.p.: 168-169 °C; 1H NMR (400
MHz, CDCl3): δ 5.66 (d, J = 16.3 Hz, 1H, =CHAr), 6.58 (d, J
= 8.0 Hz, 1H, ArH), 6.66 (d, J = 16.3 Hz, 1H, =CHAr), 7.19
(d, J = 8.2 Hz, 2H, ArH), 7.30 (dd, J = 8.4 Hz, 2.0 Hz, 1H,
ArH), 7.36 (d, J = 8.6 Hz, 1H, ArH), 7.58 (d, J = 8.8 Hz, 1H,
ArH, 7.64 (s, 1H, =CHAr), 7.66 (m, 4H, ArH), 7.67 (m, 4H,
ArH), 7.91 (m, 9H, ArH); 13C NMR (400 MHz, CDCl3): δ
168, 164, 142, 136, 135.5, 134.2, 134, 133.7, 133.4, 132.3,
131.4, 130.9, 129.2, 128.5, 128.3, 128, 126.2, 125.9, 125.6,
125.4, 125.3, 125.1, 124.6, 123.7, 123.4, 120.7, 118.7, 112,
109.4; IR (KBr, νmax, cm–1): 3053, 1716, 1627, 1578, 1405,
918, 776, 734; Anal. calcd. (%) for C40H26N2O: C: 87.25; H,
4.76; N, 5.09; Found: C: 87.21; H, 4.76; N, 5.05.
5-Benzylidene-3-naphthalen-1-yl-2-(2-naphthalen-1-
yl-vinyl)-3,5-dihydro-imidazol-4-one (a): Yellow powder;
Yield 80 %; m.p.: 143-144 °C; 1H NMR (400 MHz, CDCl3): δ
5.60 (d, J = 16.2 Hz, 1H, =CHAr), 6.55 (d, J = 7.8 Hz, 1H,
ArH), 6.61 (d, J = 16.2 Hz, 1H, =CHAr), 7.16 (d, J = 8.0 Hz,
2H, ArH), 7.21 (m, 3H, ArH), 7.28 (d, J = 8.4 Hz, 2H, ArH),
7.36 (d, J = 8.5 Hz, 1H, ArH), 7.55 (d, J = 8.6 Hz, 2H, ArH),
7.60 (s, 1H, =CHAr), 7.66 (m, 4H, ArH),7.68 (m, 4H, ArH);
13C NMR (400 MHz, CDCl3): δ 168, 164, 142, 136, 135.5,
134.9, 134.5, 134, 133.4, 132.3, 130.9, 128.5, 128.4, 128,
127.7, 126.2, 126, 125.9, 125.6, 125.4, 124.6, 123.4, 120.7,
118, 112, 109; IR (KBr, νmax, cm–1): 3057, 1718, 1688, 1641,
1510, 1405, 771, 799, 691; Anal. calcd. (%) for C32H22N2O:
C: 85.31; H, 4.92; N, 6.22; Found: C: 85.28; H, 4.90; N, 6.18.
2-(2-Anthracen-9-yl-vinyl)-5-benzylidene-3-naphthalen-
1-yl-3,5-dihydro-imidazol-4-one (b): Dark Yellow powder;
Yield 85 %; m.p.: 162-163 °C;. 1H NMR (400 MHz, CDCl3):
δ 5.61 (d, J = 16.1 Hz, 1H, =CHAr), 6.58 (d, J = 8.0 Hz, 1H,
ArH), 6.67 (d, J = 16.1 Hz, 1H, =CHAr), 7.20 (d, 8.3 Hz, 2H,
ArH), 7.30 (d, J = 8.5 Hz, 2H, ArH), 7.25 (m, 3H, ArH), 7.65
4-[1-Naphthalen-1-yl-2-(2-naphthalen-1-yl-vinyl)-5-
oxo-1,5-dihydro-imidazol-4-ylidenemethyl]-benzaldehyde
(e): Red Powder;Yield 90 %; m.p.: 160-161 °C; 1H NMR (400
MHz, CDCl3): δ 5.65 (d, J = 16.4 Hz, 1H, =CHAr), 6.58 (d,
J = 7.8 Hz, 1H, ArH), 6.68 (d, J = 16.4 Hz, 1H, =CHAr), 7.17
(d, J = 8.0 Hz, 2H, ArH), 7.27 (dd, J = 8.2 Hz, 1.8 Hz, 1H,
ArH), 7.36 (d, J = 8.5 Hz, 1H, ArH), 7.49 (d, J = 8.7 Hz, 2H,
ArH), 7.56 (d, J = 8.8 Hz, 1H, ArH), 7.63 (s, 1H, =CHAr),
7.67 (m, 4H, ArH), 7.69 (m, 4H, ArH), 7.76 (d, J = 8.7 Hz,
2H, ArH), 9.87 (s, 1H, -CHO); 13C NMR (400 MHz, CDCl3):
δ 190, 168, 164, 142, 140.7, 136, 135.9, 135.5, 134.5, 134.2,
133.4, 132.3, 130.9, 129.6, 128.5, 138.3, 128, 126.7, 126.2,
125.9, 125.6, 125.4, 124.6, 124.4, 123.7, 123.4, 120.7, 118.7,
112, 109.4; IR (KBr, νmax, cm–1): 3253, 3052, 2920, 1674, 1602,
1501, 1379, 825, 771, 540; Anal. calcd. (%) for C33H22N2O2:
C: 82.83; H, 4.63; N, 5.85; Found: C: 82.80; H, 4.62; N, 5.80.
4-[2-(2-Anthracen-9-yl-vinyl)-1-naphthalen-1-yl-5-
oxo-1,5-dihydro-imidazol-4-ylidenemethyl]-benzaldehyde
(f): Red powder;Yield 80 %; m.p.: 175-176 °C; 1H NMR (400
MHz, CDCl3): δ 5.66 (d, J = 16.4 Hz, 1H, =CHAr), 6.58 (d,
J = 8.1 Hz, 1H, ArH), 6.68 (d, J = 16.4 Hz, 1H, =CHAr), 7.20
(d, J = 8.3 Hz, 2H, ArH), 7.48 (d, J = 8.5 Hz, 2H, ArH), 7.64
(s, 1H, =CHAr), 7.67 (m 4H, ArH), 7.78 (d, J = 8.5 Hz, 2H,
ArH), 7.92 (m, 9H, ArH), 9.88 (s, 1H, -CHO); 13C NMR (400
MHz, CDCl3): δ 190, 168, 164, 142, 140.7, 136, 135.9, 134.5,
134.2, 133.7, 132.3, 131.4, 129.6, 129.2, 128.3, 126.7, 126.2,
125.9, 125.6, 125.3, 125.1, 124.6, 123.4, 120.7, 118.7, 109.4;
IR (KBr, νmax, cm–1): 3255, 3050, 1713, 1674, 1627, 1597,
1501, 1377, 825, 771, 542; Anal. calcd. (%) for C37H24N2O2:
C: 84.07; H, 4.58; N, 5.30; Found: C: 84.05; H, 4.53; N, 5.27.
4-[2-(2-Naphthalen-1-yl-vinyl)-5-oxo-1-(4-phenylazo-
phenyl)-1,5-dihydro-imidazol-4-ylidenemethyl]-benzaldehyde
(s, 1H, =CHAr), 7.66 (m, 4H, ArH), 7.90 (m, 9H, ArH); 13
C
NMR (400 MHz, CDCl3): δ 168, 164, 142, 136, 134.9, 134.2,
134, 133.7, 132.3, 131.4, 129.2, 128.4, 128.3, 127.7, 126.2,
125.9, 125.6, 125.3, 125.1, 124.6, 123.4, 120.7, 118.7, 112,
109.4; IR (KBr, νmax, cm–1): 3055, 2925, 2856, 1717, 1631,
1518, 1437, 923, 774, 691; Anal. calcd. (%) for C36H24N2O:
C: 86.38; H, 4.83; N, 5.60; Found: C: 86.34; H, 4.80; N, 5.58.
3-Naphthalen-1-yl-5-naphthalen-1-ylmethylene-2-(2-
naphthalen-1-yl-vinyl)-3,5-dihydro-imidazol-4-one (c):
Orange crystals;Yield 90 %; m.p.: 154-155 °C; 1H NMR (400
MHz, CDCl3): δ 5.65 (d, J = 16.4 Hz, 1H, =CHAr), 6.58 (d, J
= 7.9 Hz, 1H, ArH), 6.68 (d, J = 16.4 Hz, 1H, =CHAr), 7.18
(d, 8.0 Hz, 2H, ArH), 7.27 (dd, J = 8.2 Hz, 1,8 Hz, 1H, ArH),
7.28 (dd, J = 8.2 Hz, 1.8 Hz, 1H, ArH), 7.36 (d, J = 8.5 Hz,
1H, ArH), 7.37 (d, J = 8.5 Hz, 1H, ArH), 7.55 (d, J = 8.6hz,
1H,ArH), 7.56 (d, J = 8.6 Hz, 1H,ArH), 7.64 (s, 1H, =CHAr),
7.66 (m, 4H, ArH), 7.67 (m, 4H, ArH), 7.69 (m, 4H, ArH); 13C
NMR (400 MHz, CDCl3): δ 168, 164, 142, 136, 135.5, 134.5,
134.2, 133.4, 132.3, 128.5, 128.3, 128, 126.2, 125.9, 125.4,
125.6, 125.4, 124.6, 123.7, 123.4, 120.7, 118.7, 112, 109.4;
IR (KBr, νmax, cm–1): 3242, 3001, 1699, 1652, 1507, 1437,
774, 694, 605; Anal. calcd. (%) for C36H24N2O: C: 86.38; H,
4.83; N, 5.60; Found: C: 86.35; H, 4.80; N, 5.55.
1
(g): Red powder; Yield 88 %; m.p.: 150-151 °C; H NMR
(400 MHz, CDCl3): δ 5.65 (d, J = 16.4 Hz, 1H, =CHAr), 6.68
(d, J = 16.4 Hz, 1H, =CHAr), 7.27 (dd, J = 8.2 Hz, 1.8 Hz,
1H, ArH), 7.36 (d, J = 8.5 Hz, 1H, ArH), 7.46 (m, 3H, ArH),
7.49 (d, J = 8.7 Hz, 2H, ArH), 7.55 (d, J = 8.6 Hz, 1H, ArH),
7.58 (d, J = 8.8 Hz, 1H, ArH), 7.64 (s, 1H, =CHAr), 7.67 (m,
4H, ArH), 7.76 (d, J = 9.0 Hz, 2H, ArH), 7.84 (d, J = 8.6 Hz,
2H, ArH), 7.91 (d, J = 8.6 Hz, 2H, ArH), 7.93 (d, J = 8.6 Hz,
2H, ArH), 9.87 (s, 1H, -CHO); 13C NMR (400 MHz, CDCl3):
δ 190, 168, 164, 152.5, 148.1, 140.7, 136, 135.9, 135.5, 133.4,
132.3, 130.9, 130.7, 129.6, 128.8, 128.5, 128, 126.7, 125.9,
125.6, 125.4, 123.7, 123.4, 122.9, 122.7, 120.7, 112; IR (KBr,
2-(2-Anthracen-9-yl-vinyl)-3-naphthalen-1-yl-5-
naphthalen-1-ylmethylene-3,5-dihydro-imidazol-4-one (d):
ν
max, cm–1): 3263, 3050, 1671, 1598, 1503, 1380, 828, 768,